 | • レポートコード：GIR-105X03703 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、特許漢方薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。特許漢方薬の種類別市場規模（シロップ、液体、錠剤、その他）、用途別市場規模（オンライン販売、オフライン販売）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・特許漢方薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Shanghai Pharmaceutical (Group) Co., Ltd.、China Pharmaceutical Group Corporation、Guangzhou Pharmaceutical Group Co., Ltd.、Tianjin Pharmaceutical Group Co., Ltd.、Harbin Pharmaceutical Group Co., Ltd、Nanjing Pharmaceutical Industry (Group) Co., Ltd.、North China Pharmaceutical Group Co., Ltd.、Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.、Taiji Group Co., Ltd.、Xinhualu Anti-Pharmaceutical Group Co., Ltd.、Nanjing Pharmaceutical Co., Ltd、Chongqing Pharmaceutical Co., Ltd、Hangzhou Huadong Pharmaceutical Group Co., Ltd.、Jiangxi Pharmaceutical Group Corporation、Shijiazhuang Pharmaceutical Group Co., Ltd.、Northeast Pharmaceutical Group Co., Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：シロップ、液体、錠剤、その他 ・用途別分析2016年-2026年：オンライン販売、オフライン販売 ・特許漢方薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・特許漢方薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・特許漢方薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・特許漢方薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・特許漢方薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chinese Patent Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chinese Patent Medicine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Chinese Patent Medicine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chinese Patent Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Syrup
Liquid
Tablet
Others
Market segment by Application can be divided into
Online Sales
Offline Sales
The key market players for global Chinese Patent Medicine market are listed below:
Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Chinese Patent Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chinese Patent Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Syrup
1.2.3 Liquid
1.2.4 Tablet
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Chinese Patent Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Chinese Patent Medicine Market Size & Forecast
1.4.1 Global Chinese Patent Medicine Sales in Value (2016-2026))
1.4.2 Global Chinese Patent Medicine Sales in Volume (2016-2026)
1.4.3 Global Chinese Patent Medicine Price by Type (2016-2026) & (USD/MT)
1.5 Global Chinese Patent Medicine Production Capacity Analysis
1.5.1 Global Chinese Patent Medicine Total Production Capacity (2016-2026)
1.5.2 Global Chinese Patent Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chinese Patent Medicine Market Drivers
1.6.2 Chinese Patent Medicine Market Restraints
1.6.3 Chinese Patent Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Shanghai Pharmaceutical (Group) Co., Ltd.
2.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Details
2.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Major Business
2.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product and Services
2.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 China Pharmaceutical Group Corporation
2.2.1 China Pharmaceutical Group Corporation Details
2.2.2 China Pharmaceutical Group Corporation Major Business
2.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Product and Services
2.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Guangzhou Pharmaceutical Group Co., Ltd.
2.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Details
2.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Major Business
2.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Tianjin Pharmaceutical Group Co., Ltd.
2.4.1 Tianjin Pharmaceutical Group Co., Ltd. Details
2.4.2 Tianjin Pharmaceutical Group Co., Ltd. Major Business
2.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Harbin Pharmaceutical Group Co., Ltd
2.5.1 Harbin Pharmaceutical Group Co., Ltd Details
2.5.2 Harbin Pharmaceutical Group Co., Ltd Major Business
2.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product and Services
2.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
2.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Details
2.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Major Business
2.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product and Services
2.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 North China Pharmaceutical Group Co., Ltd.
2.7.1 North China Pharmaceutical Group Co., Ltd. Details
2.7.2 North China Pharmaceutical Group Co., Ltd. Major Business
2.7.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
2.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Details
2.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Major Business
2.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Taiji Group Co., Ltd.
2.9.1 Taiji Group Co., Ltd. Details
2.9.2 Taiji Group Co., Ltd. Major Business
2.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Product and Services
2.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
2.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Details
2.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Major Business
2.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Nanjing Pharmaceutical Co., Ltd
2.11.1 Nanjing Pharmaceutical Co., Ltd Details
2.11.2 Nanjing Pharmaceutical Co., Ltd Major Business
2.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product and Services
2.11.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Chongqing Pharmaceutical Co., Ltd
2.12.1 Chongqing Pharmaceutical Co., Ltd Details
2.12.2 Chongqing Pharmaceutical Co., Ltd Major Business
2.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product and Services
2.12.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
2.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Details
2.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Major Business
2.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Jiangxi Pharmaceutical Group Corporation
2.14.1 Jiangxi Pharmaceutical Group Corporation Details
2.14.2 Jiangxi Pharmaceutical Group Corporation Major Business
2.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product and Services
2.14.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
2.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Details
2.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Major Business
2.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Northeast Pharmaceutical Group Co., Ltd.
2.16.1 Northeast Pharmaceutical Group Co., Ltd. Details
2.16.2 Northeast Pharmaceutical Group Co., Ltd. Major Business
2.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
2.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Chinese Patent Medicine Sales by Manufacturer
3.1 Global Chinese Patent Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chinese Patent Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chinese Patent Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Chinese Patent Medicine Manufacturer Market Share
3.4.2 Top 6 Chinese Patent Medicine Manufacturer Market Share
3.5 Global Chinese Patent Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chinese Patent Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chinese Patent Medicine Market Size by Region
4.1.1 Global Chinese Patent Medicine Sales in Volume by Region (2016-2026)
4.1.2 Global Chinese Patent Medicine Revenue by Region (2016-2026)
4.2 North America Chinese Patent Medicine Revenue (2016-2026)
4.3 Europe Chinese Patent Medicine Revenue (2016-2026)
4.4 Asia-Pacific Chinese Patent Medicine Revenue (2016-2026)
4.5 South America Chinese Patent Medicine Revenue (2016-2026)
4.6 Middle East and Africa Chinese Patent Medicine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chinese Patent Medicine Sales in Volume by Type (2016-2026)
5.2 Global Chinese Patent Medicine Revenue by Type (2016-2026)
5.3 Global Chinese Patent Medicine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chinese Patent Medicine Sales in Volume by Application (2016-2026)
6.2 Global Chinese Patent Medicine Revenue by Application (2016-2026)
6.3 Global Chinese Patent Medicine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chinese Patent Medicine Sales by Type (2016-2026)
7.2 North America Chinese Patent Medicine Sales by Application (2016-2026)
7.3 North America Chinese Patent Medicine Market Size by Country
7.3.1 North America Chinese Patent Medicine Sales in Volume by Country (2016-2026)
7.3.2 North America Chinese Patent Medicine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chinese Patent Medicine Sales by Type (2016-2026)
8.2 Europe Chinese Patent Medicine Sales by Application (2016-2026)
8.3 Europe Chinese Patent Medicine Market Size by Country
8.3.1 Europe Chinese Patent Medicine Sales in Volume by Country (2016-2026)
8.3.2 Europe Chinese Patent Medicine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chinese Patent Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Chinese Patent Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Chinese Patent Medicine Market Size by Region
9.3.1 Asia-Pacific Chinese Patent Medicine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chinese Patent Medicine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chinese Patent Medicine Sales by Type (2016-2026)
10.2 South America Chinese Patent Medicine Sales by Application (2016-2026)
10.3 South America Chinese Patent Medicine Market Size by Country
10.3.1 South America Chinese Patent Medicine Sales in Volume by Country (2016-2026)
10.3.2 South America Chinese Patent Medicine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chinese Patent Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Chinese Patent Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Chinese Patent Medicine Market Size by Country
11.3.1 Middle East & Africa Chinese Patent Medicine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chinese Patent Medicine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chinese Patent Medicine Typical Distributors
12.3 Chinese Patent Medicine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Chinese Patent Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chinese Patent Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Shanghai Pharmaceutical (Group) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Shanghai Pharmaceutical (Group) Co., Ltd. Major Business
Table 5. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product and Services
Table 6. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 8. China Pharmaceutical Group Corporation Major Business
Table 9. China Pharmaceutical Group Corporation Chinese Patent Medicine Product and Services
Table 10. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Guangzhou Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. Guangzhou Pharmaceutical Group Co., Ltd. Major Business
Table 13. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 14. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Tianjin Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. Tianjin Pharmaceutical Group Co., Ltd. Major Business
Table 17. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 18. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Harbin Pharmaceutical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Harbin Pharmaceutical Group Co., Ltd Major Business
Table 21. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product and Services
Table 22. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Major Business
Table 25. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product and Services
Table 26. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. North China Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. North China Pharmaceutical Group Co., Ltd. Major Business
Table 29. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 30. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Major Business
Table 33. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 34. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Taiji Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Taiji Group Co., Ltd. Major Business
Table 37. Taiji Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 38. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Major Business
Table 41. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 42. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Nanjing Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Nanjing Pharmaceutical Co., Ltd Major Business
Table 45. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product and Services
Table 46. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Chongqing Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Chongqing Pharmaceutical Co., Ltd Major Business
Table 49. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product and Services
Table 50. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Major Business
Table 53. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 54. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Jiangxi Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Jiangxi Pharmaceutical Group Corporation Major Business
Table 57. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product and Services
Table 58. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Shijiazhuang Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. Shijiazhuang Pharmaceutical Group Co., Ltd. Major Business
Table 61. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 62. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Northeast Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Northeast Pharmaceutical Group Co., Ltd. Major Business
Table 65. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 66. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Chinese Patent Medicine Sales by Manufacturer (2019-2021e) & (K MT)
Table 68. Global Chinese Patent Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Chinese Patent Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Chinese Patent Medicine Production Capacity by Company, (K MT): 2020 VS 2021
Table 71. Head Office and Chinese Patent Medicine Production Site of Key Manufacturer
Table 72. Global Chinese Patent Medicine Sales by Region (2016-2021e) & (K MT)
Table 73. Global Chinese Patent Medicine Sales by Region (2021-2026) & (K MT)
Table 74. Global Chinese Patent Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Chinese Patent Medicine Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Chinese Patent Medicine Sales by Type (2016-2021e) & (K MT)
Table 77. Global Chinese Patent Medicine Sales by Type (2021-2026) & (K MT)
Table 78. Global Chinese Patent Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Chinese Patent Medicine Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Chinese Patent Medicine Price by Type (2016-2021e) & (USD/MT)
Table 81. Global Chinese Patent Medicine Price by Type (2021-2026) & (USD/MT)
Table 82. Global Chinese Patent Medicine Sales by Application (2016-2021e) & (K MT)
Table 83. Global Chinese Patent Medicine Sales by Application (2021-2026) & (K MT)
Table 84. Global Chinese Patent Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Chinese Patent Medicine Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Chinese Patent Medicine Price by Application (2016-2021e) & (USD/MT)
Table 87. Global Chinese Patent Medicine Price by Application (2021-2026) & (USD/MT)
Table 88. North America Chinese Patent Medicine Sales by Country (2016-2021e) & (K MT)
Table 89. North America Chinese Patent Medicine Sales by Country (2021-2026) & (K MT)
Table 90. North America Chinese Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Chinese Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Chinese Patent Medicine Sales by Type (2016-2021e) & (K MT)
Table 93. North America Chinese Patent Medicine Sales by Type (2021-2026) & (K MT)
Table 94. North America Chinese Patent Medicine Sales by Application (2016-2021e) & (K MT)
Table 95. North America Chinese Patent Medicine Sales by Application (2021-2026) & (K MT)
Table 96. Europe Chinese Patent Medicine Sales by Country (2016-2021e) & (K MT)
Table 97. Europe Chinese Patent Medicine Sales by Country (2021-2026) & (K MT)
Table 98. Europe Chinese Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Chinese Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Chinese Patent Medicine Sales by Type (2016-2021e) & (K MT)
Table 101. Europe Chinese Patent Medicine Sales by Type (2021-2026) & (K MT)
Table 102. Europe Chinese Patent Medicine Sales by Application (2016-2021e) & (K MT)
Table 103. Europe Chinese Patent Medicine Sales by Application (2021-2026) & (K MT)
Table 104. Asia-Pacific Chinese Patent Medicine Sales by Region (2016-2021e) & (K MT)
Table 105. Asia-Pacific Chinese Patent Medicine Sales by Region (2021-2026) & (K MT)
Table 106. Asia-Pacific Chinese Patent Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Chinese Patent Medicine Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Chinese Patent Medicine Sales by Type (2016-2021e) & (K MT)
Table 109. Asia-Pacific Chinese Patent Medicine Sales by Type (2021-2026) & (K MT)
Table 110. Asia-Pacific Chinese Patent Medicine Sales by Application (2016-2021e) & (K MT)
Table 111. Asia-Pacific Chinese Patent Medicine Sales by Application (2021-2026) & (K MT)
Table 112. South America Chinese Patent Medicine Sales by Country (2016-2021e) & (K MT)
Table 113. South America Chinese Patent Medicine Sales by Country (2021-2026) & (K MT)
Table 114. South America Chinese Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Chinese Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Chinese Patent Medicine Sales by Type (2016-2021e) & (K MT)
Table 117. South America Chinese Patent Medicine Sales by Type (2021-2026) & (K MT)
Table 118. South America Chinese Patent Medicine Sales by Application (2016-2021e) & (K MT)
Table 119. South America Chinese Patent Medicine Sales by Application (2021-2026) & (K MT)
Table 120. Middle East & Africa Chinese Patent Medicine Sales by Country (2016-2021e) & (K MT)
Table 121. Middle East & Africa Chinese Patent Medicine Sales by Country (2021-2026) & (K MT)
Table 122. Middle East & Africa Chinese Patent Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Chinese Patent Medicine Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Chinese Patent Medicine Sales by Type (2016-2021e) & (K MT)
Table 125. Middle East & Africa Chinese Patent Medicine Sales by Type (2021-2026) & (K MT)
Table 126. Middle East & Africa Chinese Patent Medicine Sales by Application (2016-2021e) & (K MT)
Table 127. Middle East & Africa Chinese Patent Medicine Sales by Application (2021-2026) & (K MT)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Chinese Patent Medicine Typical Distributors
Table 131. Chinese Patent Medicine Typical Customers
List of Figures
Figure 1. Chinese Patent Medicine Picture
Figure 2. Global Chinese Patent Medicine Sales Market Share by Type in 2020
Figure 3. Syrup
Figure 4. Liquid
Figure 5. Tablet
Figure 6. Others
Figure 7. Global Chinese Patent Medicine Sales Market Share by Application in 2020
Figure 8. Online Sales
Figure 9. Offline Sales
Figure 10. Global Chinese Patent Medicine Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Chinese Patent Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Chinese Patent Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Chinese Patent Medicine Sales (2016-2026) & (K MT)
Figure 32. Global Chinese Patent Medicine Production Capacity (2016-2026) & (K MT)
Figure 33. Global Chinese Patent Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Chinese Patent Medicine Market Drivers
Figure 35. Chinese Patent Medicine Market Restraints
Figure 36. Chinese Patent Medicine Market Trends
Figure 37. Global Chinese Patent Medicine Sales Market Share by Manufacturer in 2020
Figure 38. Global Chinese Patent Medicine Revenue Market Share by Manufacturer in 2020
Figure 39. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Chinese Patent Medicine Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Chinese Patent Medicine Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Chinese Patent Medicine Sales Market Share by Region (2016-2026)
Figure 43. Global Chinese Patent Medicine Revenue Market Share by Region (2016-2026)
Figure 44. North America Chinese Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 45. Europe Chinese Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Chinese Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 47. South America Chinese Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Chinese Patent Medicine Revenue (2016-2026) & (USD Million)
Figure 49. Global Chinese Patent Medicine Sales Market Share by Type (2016-2026)
Figure 50. Global Chinese Patent Medicine Revenue Market Share by Type (2016-2026)
Figure 51. Global Chinese Patent Medicine Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Chinese Patent Medicine Sales Market Share by Application (2016-2026)
Figure 53. Global Chinese Patent Medicine Revenue Market Share by Application (2016-2026)
Figure 54. Global Chinese Patent Medicine Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Chinese Patent Medicine Sales Market Share by Country (2016-2026)
Figure 56. North America Chinese Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 57. North America Chinese Patent Medicine Sales Market Share by Type (2016-2026)
Figure 58. North America Chinese Patent Medicine Sales Market Share by Application (2016-2026)
Figure 59. Europe Chinese Patent Medicine Sales Market Share by Country (2016-2026)
Figure 60. Europe Chinese Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 61. Europe Chinese Patent Medicine Sales Market Share by Type (2016-2026)
Figure 62. Europe Chinese Patent Medicine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Chinese Patent Medicine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Chinese Patent Medicine Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Chinese Patent Medicine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Chinese Patent Medicine Sales Market Share by Application (2016-2026)
Figure 67. South America Chinese Patent Medicine Sales Market Share by Country (2016-2026)
Figure 68. South America Chinese Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 69. South America Chinese Patent Medicine Sales Market Share by Type (2016-2026)
Figure 70. South America Chinese Patent Medicine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Chinese Patent Medicine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Chinese Patent Medicine Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Chinese Patent Medicine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Chinese Patent Medicine Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の特許医薬品市場 2021：企業別、地域別、種類・用途別 The Patent Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…- 特許医学の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Today many drug companies which have produced drugs with which the public is very familiar, like Plavix®, Lipitor® and Abilify® Scope of the Report: This report focuses on the Patent Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Afri…
- スパイシースティック（中華スナック）の世界市場2018-2025 In 2018, the global Spicy Sticks(Chinese Snack) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Spicy Sticks(Chinese Sna…
- ダックネック(中国系おやつ)の世界市場2018-2025 In 2018, the global Duck Neck(Chinese Snack) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Duck Neck(Chinese Snack). T…
- AnHuaHeiCha(ChineseBlackTeaLeaves)の世界市場2018-2025 In 2018, the global An Hua Hei Cha (Chinese Black Tea Leaves) market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for An Hua Hei…